相似文献
1
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2025 Apr;211(4):650-654. doi: 10.1164/rccm.202406-1143RL.
3
A case of hermansky-pudlak syndrome with pulmonary sarcoidosis.
J Clin Aesthet Dermatol. 2009 Oct;2(10):41-4.
4
[Familial pulmonary fibrosis in 2 Mexican sisters with Hermansky-Pudlak syndrome].
Arch Bronconeumol. 2009 Aug;45(8):408-10. doi: 10.1016/j.arbres.2009.01.002. Epub 2009 May 2.
5
Hermansky-Pudlak Syndrome: An unusual pattern of pulmonary fibrosis.
Respir Med Case Rep. 2024 Sep 26;52:102123. doi: 10.1016/j.rmcr.2024.102123. eCollection 2024.
6
Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies.
AJR Am J Roentgenol. 2002 Oct;179(4):887-92. doi: 10.2214/ajr.179.4.1790887.
7
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
medRxiv. 2024 May 17:2024.05.16.24307300. doi: 10.1101/2024.05.16.24307300.
8
Characterization of melanosomes in murine Hermansky-Pudlak syndrome: mechanisms of hypopigmentation.
J Invest Dermatol. 2004 Feb;122(2):452-60. doi: 10.1046/j.0022-202X.2004.22117.x.
9
Hermansky-Pudlak syndrome: Gene therapy for pulmonary fibrosis.
Mol Genet Metab. 2022 Sep-Oct;137(1-2):187-191. doi: 10.1016/j.ymgme.2022.08.008. Epub 2022 Sep 2.
10
Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism.
Mol Genet Metab. 2016 Nov;119(3):284-287. doi: 10.1016/j.ymgme.2016.08.009. Epub 2016 Sep 3.
引用本文的文献
1
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis.
JCI Insight. 2025 Jul 3;10(15). doi: 10.1172/jci.insight.187967. eCollection 2025 Aug 8.
2
Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failure.
Am J Med Sci. 2025 Jun 4. doi: 10.1016/j.amjms.2025.06.003.
3
Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1.
Orphanet J Rare Dis. 2025 May 12;20(1):226. doi: 10.1186/s13023-025-03758-5.
本文引用的文献
1
CB R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.
Clin Transl Med. 2021 Jul;11(7):e471. doi: 10.1002/ctm2.471.
2
Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.
Front Pharmacol. 2021 Mar 18;12:644671. doi: 10.3389/fphar.2021.644671. eCollection 2021.
3
Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease.
Eur Respir Rev. 2021 Feb 2;30(159). doi: 10.1183/16000617.0193-2020. Print 2021 Mar 31.
4
The therapeutic potential of second and third generation CBR antagonists.
Pharmacol Ther. 2020 Apr;208:107477. doi: 10.1016/j.pharmthera.2020.107477. Epub 2020 Jan 9.
5
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.
Am J Respir Cell Mol Biol. 2020 Feb;62(2):178-190. doi: 10.1165/rcmb.2018-0147OC.
6
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.
JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.92281.
7
Hermansky-Pudlak Syndrome.
Clin Chest Med. 2016 Sep;37(3):505-11. doi: 10.1016/j.ccm.2016.04.012. Epub 2016 Jun 30.
8
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis.
Am J Respir Cell Mol Biol. 2014 Mar;50(3):605-13. doi: 10.1165/rcmb.2013-0025OC.
9
Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis.
Chest. 2011 Dec;140(6):1590-1597. doi: 10.1378/chest.10-2545. Epub 2011 May 26.
10
Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.
Chest. 2000 Jan;117(1):129-36. doi: 10.1378/chest.117.1.129.
Zotero 插件